Skip to main content
. 2020 Jan 13;14(1):e0007984. doi: 10.1371/journal.pntd.0007984

Table 2. Changes in cryptococcal antigen titers and viable yeasts in the CSF of the 14 patients with cryptococcal meningitis.

Case ID CrAg titer Culture Outcome
Day 1 Day 15/29 Day 30/59 Day 60/79 Day 90/120
CRY017 ≥1:1280 pos day 1 dead day 4
CRY033 1:20 1:10 neg day 11 dead day 69
CRY041 1:640 1:320 1:320 1:160 1:40 neg day 104 dead day 141
CRY061 ≥1:1280 pos day 1 dead day 12
CRY067 1:320 1:640 1:40 1:40 neg day 39 dead day 68
CRY069 ≥1:1280 1:1280 1:40 1:40 neg day 28 alive day 197
CRY070 ≥1:1280 ≥1:1280 ≥1:1280 ≥1:1280 pos day 56 dead day 73
CRY094 ≥1:1280 pos day 1 dead day 19
CRY101 ≥1:1280 pos day 1 dead day 4
CRY112 1:640 1:320 1:160 1:160 neg day 122 alive day 160
CRY114 ≥1:1280 pos day 1 dead day 12
CRY124 1:320 na alive day 120
CRY128 ≥1:1280 1:80 1:40 1:40 1:40 neg day 77 alive day 120
CRY130 1:1280 pos day 1 lost to follow-up

na, not applicable (insufficient quantity)

Note: all patients were treated with fluconazole, except for patient CRY128, who received amphotericin B and high-dose fluconazole